Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
RSV, COVID and flu
Yes, you can get the COVID, flu, and RSV vaccines at once. Here are the pros and cons
Particularly if you tend not to have vaccine side effects, getting routine shots in one go may be a convenient option.
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for manufacturers.
What to know about COVID, flu and RSV vaccines for fall virus season
Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.
COVID, RSV and flu cases expected to rise in Connecticut soon: 'Definitely upon us'
RSV rates can be expected to increase, and flu, as well as other common viruses. Human metapneumovirus tends to peak in February and March, Roberts said, as do non-COVID coronaviruses. Parainfluenza also tends to “hit in the winter,” he said.
Public shunning ‘tripledemic’ vaccines for COVID-19, flu, and RSV
The public, by and large, has not been on board with immunizations in the aftermath of the pandemic, despite public health agencies heavily campaigning this year for more people to get vaccinated against COVID-19,
What Older Adults Need to Know About Flu and COVID-19 Vaccines
Colder weather brings a change in seasons and often an uptick in flu and COVID-19 cases. The viruses that cause COVID-19 and flu keep changing and infecting thousands of people each year, with older adults being most at risk.
NHS to offer 900,000 flu and Covid vaccinations in Hampshire
Almost 900,000 appointments will be available for flu and Covid-19 vaccinations across Hampshire and the Isle of Wight.
4h
on MSN
GSK RSV shot 43% effective against severe disease in third year
GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...
23h
RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...
FiercePharma
2h
GSK touts 3-year data on RSV shot Arexvy after CDC's narrower usage recommendation
While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...
8h
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
5h
Alberta to cover pricey RSV vaccine for some older people
The Alberta government announced Monday that the RSV vaccine, Abyrsvo, will be provincially funded for Albertans, aged 60 and ...
BioPharma Dive
1h
GSK says RSV vaccine protects against disease over three seasons
Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and GSK said it expects revaccination will eventually be needed.
pulmonologyadvisor
3h
RSV Vaccine Is Recommended for Long-Term Care Facility Residents
The RSV vaccine is unequivocally recommended for adults who are residents in skilled nursing and assisted living facilities.
4h
GSK Announces Positive Data From AReSVi-006 Phase III Trial For RSV Vaccine Arexvy
GSK plc (GSK, GSK.L) announced Tuesday new data from the AReSVi-006 (Adult Respiratory Syncytial Virus) phase III trial evaluating ...
1d
Free RSV shots now available for Ontario infants: ‘A very big deal for child health’
RSV is the most harmful respiratory illness for young infants, says Dr. Jeffrey Pernica, a professor in the Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
COVID
GSK
Pfizer
Thermo Fisher
Arexvy
Feedback